Technical Analysis for ANIX - Anixa Biosciences, Inc.

Grade Last Price % Change Price Change
grade C 4.1 -3.53% -0.15
ANIX closed down 3.53 percent on Friday, August 23, 2019, on 57 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ANIX trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Crossed Above 50 DMA Bullish -3.53%
180 Bullish Setup Bullish Swing Setup -3.53%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.53%
Fell Below 50 DMA Bearish 0.86%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.86%
Inside Day Range Contraction 0.86%
Down 3 Days in a Row Weakness 0.86%
200 DMA Resistance Bearish -1.91%

Older signals for ANIX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Anixa, a cancer-focused biotechnology company, is harnessing the body's immune system in the fight against cancer. Anixa is developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body's immune response to the presence of a malignancy. It is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. Anixa also continually examines emerging technologies in complementary or related fields for further development and commercialization.
Medicine Biotechnology Cancer Medical Specialties Clinical Medicine Solid Tumors Immune System Cancer Treatments Gene Therapy Leukemia Chimeric Antigen Receptor
Is ANIX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.86
52 Week Low 3.1
Average Volume 85,824
200-Day Moving Average 4.325
50-Day Moving Average 4.1651
20-Day Moving Average 4.3348
10-Day Moving Average 4.1755
Average True Range 0.2691
ADX 23.41
+DI 13.2175
-DI 18.8192
Chandelier Exit (Long, 3 ATRs ) 4.1634
Chandelier Exit (Short, 3 ATRs ) 4.6273
Upper Bollinger Band 4.7259
Lower Bollinger Band 3.9437
Percent B (%b) 0.2
BandWidth 18.044662
MACD Line -0.0413
MACD Signal Line -0.0067
MACD Histogram -0.0346
Fundamentals Value
Market Cap 62 Million
Num Shares 15.1 Million
EPS -0.60
Price-to-Earnings (P/E) Ratio -6.83
Price-to-Sales 51.61
Price-to-Book 5.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.46
Resistance 3 (R3) 4.48 4.38 4.40
Resistance 2 (R2) 4.38 4.29 4.37 4.38
Resistance 1 (R1) 4.24 4.23 4.19 4.22 4.36
Pivot Point 4.14 4.14 4.12 4.13 4.14
Support 1 (S1) 4.00 4.05 3.95 3.98 3.84
Support 2 (S2) 3.90 3.99 3.89 3.82
Support 3 (S3) 3.76 3.90 3.80
Support 4 (S4) 3.74